NCT00562419 2010-10-27
CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
Adnexus, A Bristol-Myers Squibb R&D Company
Phase 2 Unknown
Adnexus, A Bristol-Myers Squibb R&D Company
Adnexus, A Bristol-Myers Squibb R&D Company